KemPharm Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
KemPharm (KMPH) IPO Opens Up 7%
April 16, 2015 10:51 AM EDTToday's IPO for KemPharm (NASDAQ: KMPH) opened for trading at $11.75 after pricing 5,090,909 shares of its common stock at a price to the public of $11.00 per share.
Cowen and Company and RBC Capital Markets are acting as joint book-running managers for the offering.... More
